Trupanion, Inc. (NASDAQ:TRUP) Insider Brenna Mcgibney Sells 5,000 Shares

Trupanion, Inc. (NASDAQ:TRUP) insider Brenna Mcgibney sold 5,000 shares of the stock in a transaction on Friday, March 7th. The stock was sold at an average price of $32.99, for a total transaction of $164,950.00. Following the sale, the insider now directly owns 3,738 shares in the company, valued at $123,316.62. This trade represents a 57.22 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Trupanion Price Performance

Shares of NASDAQ TRUP opened at $33.20 on Wednesday. The firm has a market cap of $1.41 billion, a PE ratio of -144.35, a PEG ratio of 6.02 and a beta of 1.70. The firm has a fifty day moving average of $43.50 and a 200 day moving average of $47.33. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.66 and a current ratio of 1.71. Trupanion, Inc. has a one year low of $19.69 and a one year high of $57.90.

Trupanion (NASDAQ:TRUP) last announced its quarterly earnings data on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.02). The firm had revenue of $337.31 million during the quarter, compared to analysts’ expectations of $335.41 million. Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. As a group, research analysts predict that Trupanion, Inc. will post 0.13 EPS for the current fiscal year.

Analyst Ratings Changes

A number of analysts recently issued reports on the stock. Piper Sandler lowered their price target on shares of Trupanion from $57.00 to $52.00 and set an “overweight” rating on the stock in a report on Thursday, February 20th. Stifel Nicolaus cut their price target on shares of Trupanion from $44.00 to $41.00 and set a “hold” rating for the company in a report on Thursday, February 20th. Two equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, Trupanion currently has an average rating of “Moderate Buy” and an average target price of $46.60.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its holdings in Trupanion by 1.3% in the 4th quarter. Vanguard Group Inc. now owns 3,596,725 shares of the financial services provider’s stock valued at $173,362,000 after purchasing an additional 45,653 shares in the last quarter. Wellington Management Group LLP grew its holdings in Trupanion by 4.4% in the 3rd quarter. Wellington Management Group LLP now owns 3,393,879 shares of the financial services provider’s stock valued at $142,475,000 after buying an additional 142,156 shares in the last quarter. FMR LLC grew its holdings in Trupanion by 55,963.7% in the 3rd quarter. FMR LLC now owns 1,172,293 shares of the financial services provider’s stock valued at $49,213,000 after buying an additional 1,170,202 shares in the last quarter. Marshall Wace LLP grew its holdings in Trupanion by 6.9% in the 4th quarter. Marshall Wace LLP now owns 901,645 shares of the financial services provider’s stock valued at $43,459,000 after buying an additional 57,804 shares in the last quarter. Finally, Balyasny Asset Management L.P. grew its holdings in Trupanion by 368.2% in the 4th quarter. Balyasny Asset Management L.P. now owns 841,254 shares of the financial services provider’s stock valued at $40,548,000 after buying an additional 661,559 shares in the last quarter.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.